Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine

Clinical trial NCT00627458 · COMPLETED

Trial details

NCT number: NCT00627458
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acellular Pertussis Diphtheria Poliomyelitis Haemophilus Influenzae Type b Tetanus Hepatitis B

Start date: 2008-02-01
Primary completion: 2008-08-18
Enrollment: 403

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.